Drug intelligence / Profile preview

YME1L short hairpin RNA

Development stage
Preclinical
Lead developer
Princess Margaret Cancer Centre
Modality
Viral-delivered RNAi → In Vivo RNAi → Gene Silencing → Gene Therapies, RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intratumoral
01

Overview

YME1L short hairpin RNA is a gene-silencing therapeutic candidate designed to target Yeast mitochondrial escape 1-like 1 (YME1L), a mitochondrial ATP-dependent protease located in the intermembrane space. In the context of acute myeloid leukemia (AML), YME1L is often overexpressed and plays a critical role in maintaining mitochondrial proteostasis and preventing the leakage of mitochondrial DNA (mtDNA) into the cytoplasm. By knocking down YME1L expression, this shRNA induces AML cell differentiation and inhibits proliferation. The mechanism involves the leakage of mtDNA through VDAC channels, which subsequently activates the cGAS-STING pathway and triggers type I interferon (IFN) signaling. This approach represents a novel strategy for treating AML by leveraging mitochondrial stress and innate immune activation.

Other names
YME1L shRNAYME-1L shRNAYME 1L shRNAshYME1LshYME-1LshYME 1L
02

Targets

YME1L1 (ATP-dependent mitochondrial metalloprotease YME1L1)

Beyond the preview

Go deeper on YME1L short hairpin RNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on YME1L short hairpin RNA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call